Pharmacel® sMCC 90

Multi- and highly- functional excipient 

Superior compaction and flow properties  

Ensures formulation robustness and easy scale-up 

Oral Solid Dose
SMCC90

Product information

Pharmacel® sMCC 90, a silicified microcrystalline cellulose, developed as the synergistic solution for challenging oral solid dosage formulations. Co-processing microcrystalline cellulose with silicon dioxide increases its surface area, resulting in enhanced powder flow, superior tabletability, and improved formulation robustness.

Product types
Microcrystalline cellulose
Excipient functionality
Binder, Diluent, Filler-binder, Disintegrant
Recommended process
Direct compression, Dry blending, Wet granulation
Dosage forms
Capsule (Oral Solid Dose), Orally disintegrating tablet, Tablet, Sachet

Typical product data

Particle size distribution (μm)

X10
35
X50
110
X90
270

Bulk density (g/L)

Bulk density (g/L)
318

Hausner ratio (-)

Hausner ratio (-)
1.46

LOD (% w/w)

LOD (% w/w)
4.4

Documentation

  • ALBA Pharmacel
  • Oral Solid Dose Brochure View
  • Contaminants Statement Pharmacel
  • Food statement MCC
  • GMO Statement Microcrystalline Cellulose
  • GMP DFE Pharma India Nagpur
  • ISO 14001 DFE Pharma India Cuddalore
  • ISO 9001 DFE India Cuddalore
  • ICHQ3D - Elemental Impurities MCC
  • Ingredient declaration lactose
  • Ingredient declaration Pharmacel
  • Kosher Certificate DFE Pharma India Cuddalore
  • MSDS Pharmacel
  • Nutritional information Pharmacel
  • Ingredient Declaration Pharmacel sMCC
  • MSDS Pharmacel sMCC
  • DMF (Drug Master File)